CANNABIS, HEALTHCARE, VENTURE CAPITAL
President and CEO,
Emerald Health Therapeutics
Riaz Bandali's expertise in strategy development, global operations, driving innovation, M&A, and investment management has been developed over a 25-year career in the life sciences sector spanning contract clinical and research services, analytical instrumentation, lab services, and venture capital.
Emerald Health Therapeutics is committed to creating new consumer and patient experiences with specialty recreational, medical, and wellness-oriented cannabinoid products. The company is focused on science-based innovation and product excellence, leveraging competencies in scientific know-how and research and development. Emerald is serving consumers and patients in Canada and establishing partnerships that extend its product lines and international reach.